Clinical Outcomes of Different Stroke Prevention Strategies in Patients With Inadvertent Left Atrial Appendage

Shaohui Wu1, Jiongchao Guo1, Juan Du1

  • 1Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Left atrial appendage closure (LAAC) after ablation for persistent atrial fibrillation (AF) with inadvertent electrical isolation may reduce bleeding risk. This strategy showed comparable efficacy to long-term direct oral anticoagulants (DOACs).

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • Inadvertent left atrial appendage electrical isolation (LAAEI) during persistent atrial fibrillation (AF) ablation is linked to increased thromboembolic risk.
  • Optimal antithrombotic management following LAAEI remains undetermined.

Purpose of the Study:

  • To compare the safety and efficacy of left atrial appendage closure (LAAC) within 3 months post-ablation versus long-term direct oral anticoagulants (DOACs).
  • To evaluate outcomes in persistent AF patients experiencing inadvertent LAAEI during catheter ablation.

Main Methods:

  • Retrospective analysis of 225 patients with inadvertent LAAEI during persistent AF ablation (Jan 2019-Mar 2024).
  • Propensity score matching (PSM) created two groups (n=72 each): LAAC within 3 months and long-term DOACs.
  • Outcomes assessed included bleeding events, thromboembolic events, and atrial arrhythmia recurrence over a mean 827-day follow-up.

Main Results:

  • The LAAC group exhibited significantly lower rates of non-procedure-related major and clinically relevant nonmajor bleeding compared to the DOAC group (HR=0.417, p=0.034).
  • Thromboembolic event rates were comparable between the groups (HR=0.246, p=0.205).
  • Atrial arrhythmia recurrence rates were also similar (HR=0.939, p=0.054).

Conclusions:

  • Left atrial appendage closure (LAAC) performed within 3 months post-ablation may offer a reduced bleeding risk for patients with inadvertent LAAEI.
  • LAAC demonstrates comparable efficacy to long-term DOACs in this specific patient population.
  • LAAC is a safe and effective therapeutic strategy for managing inadvertent LAAEI during persistent AF ablation.
Abstract

Related Concept Videos